Business Coronavirus

Russia Will Start Treating Their Patients With The First Approved Drug To Treat COVID-19!

Russia Approves Corona Vaccine

Russia approved Aviifavir, an anti-influenza drug, to treat the Coronavirus patients in the country. According to The Sovereign Wealth Fund of Russia, they will start delivering the drug in June. They aim to deliver 60,000 courses of the drug to the hospitals in this month onwards.

Russia’s Health Ministry Approved The Drug Aviifavir Temporarily

The production of the drug is based on an anti-influenza drug, Favipiravir. This developed in Japan in a 50-50 venture with the Russian pharmaceutical firm ChemRar. The drug developed with the name of Avigan, which is changed later to Aviifavir. The RDIF provided money for the development and production of the drug in Russia.

Russia Approves Corona Vaccine Aviifavir

In the primary trials, 65% of the 40 COVID-19 cases tested negative after only five days of the treatment. However, the Aviifavir clinical final trials with 330 Coronavirus cases still ongoing. Meanwhile, The Ministry of Health of Russia temporarily approved the Aviifavir drug as the first-ever approved COVID-19 treatment.

RDIF And ChemRar On The Approved Drug

RDIF CEO Kirill Dmitriev told CNBC, “It’s a major step forward. We believe there are only two antiviral drugs against the virus (COVID-19) that are effective. Those are Remedesivir, by the US and Favipiravir, which also has significant promise.”

Russia Approves Corona Vaccine Aviifavir

RDIF and ChemRar stated about the official certification of Aviifavir. “Aviifavir is Russia’s first COVID-19 drug. It has shown high efficacy in treating patients with COVID-19 during clinical trials. Aviifavir received a registration certificate from the Ministry of Health of the Russian Federation. Thus, it becomes the first Favipiravir-based drug in the world approved for the COVID-19 treatment.”

Russia Being A Positive Player In The Pandemic

The UK is aiming to host a virtual Global Vaccine Summit on June 4 to increase international investment in research and development in the vaccine. But after President Trump announced the US’s withdrawal from WHO, it’s facing problems.
While RDIF confirmed, “the negative fact that lots of people trying to be competitive with other nations..articles saying ‘Russia claiming this about this drug’…we sharing very positive news..the world needs to come together…fight the virus”.

Also, check out –Β Solo Leveling Season 2: Story revolves around protagonist Sung Jin-Woo.

About the author


Figuring out dreams, majoring in Physics, learning Spanish, writing, and much more...

Add Comment

Click here to post a comment